Sophont Launches Holon-S1 to Reveal Tumor Biology from Routine Pathology Slides
SACRAMENTO, Calif., Oct. 20, 2026 /PRNewswire/ -- Sophont, a frontier medical AI startup, announces Holon-S1, a pan-cancer AI model that predicts spatial gene and biological pathway activity from routine hematoxylin and eosin (H&E) pathology slides. By using widely available pathology...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.